OFI
ofi, a leading supplier of naturally good food and beverage ingredients, today unveiled a new sustainability strategy – ‘Choices for Change’ and ambitious 2030 targets.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240618240708/en/
Choices for Change - new ofi sustainability strategy (Photo: ofi)
Global food brands and retailers are facing growing consumer demand for sustainable products, with increasing weather related and other challenges in the food supply chain and significant new sustainability linked legislation coming up. With ‘Choices for Change’, ofi will provide these companies and their consumers with specific choices to deliver long-term impact across four critical pillars: Prosperous Farmers, Thriving Communities, Climate Action, and Regenerating the Living World.
Every 2030 target in the Choices for Change strategy delivers on key customer needs, including:
- Delivering enhanced livelihood support to one million farmers, helping them to be more productive and deliver better quality ingredients.
- Cutting scope 3 emissions by 30% to offer customers verifiable, low-carbon products and ingredients and contribute to net-zero commitments.
- Bringing 2 million hectares of land under regenerative farming practices to create long-term farm resilience and products with verified positive natural impact.
To give customers more rigorous, verifiable data for sustainability decision-making and reporting, the strategy incorporates a focus on supply chain excellence. This brings traceability, data insights, risk mitigation, verification, and in-depth supplier engagement together to enable the right choices and includes ofi’s suite of award-winning tech tools like AtSource - the sustainability management system and its built in Carbon Scenario Planner for planning and costing climate action.
Launching Choices for Change on UN Sustainable Gastronomy Day, Roel van Poppel, Chief Sustainability Officer, ofi, said: “Choices for Change is the next phase in our journey, building upon and reinforcing years of experience in managing sustainability programs spanning hundreds of farming communities. Our team of over 500 sustainability experts from Côte d’Ivoire to Brazil, from Vietnam to Ghana, bring a deep understanding of and capability to solve some of the key environmental and humanitarian challenges in the food system. We offer our customers and partners the traceability, insights, capability, and choices to drive positive change.”
ofi’s leading global product platforms - cocoa, coffee, dairy, nuts, and spices - already have specific strategies or programs to address the challenges and opportunities of each product supply chain1. These strategies will be integral to delivering the targets under Choices for Change which seeks to consolidate a single set of ambitions to be implemented globally, with universal metrics and definitions for all of ofi’s operations across ~50 countries. It will be delivered in partnership with farmers, governments, civil society and ofi’s customers – including many of the world’s largest food retailers, brands, and manufacturers. ofi has a long history of partnering with customers to deliver shared sustainability goals and scale impact, with over 130 collaborative programs active today.
CEO of ofi, A. Shekhar, said: “We know that doing what’s right for communities and the planet is even more critical to our long-term commercial imperative to deliver the highest quality of food ingredients and solutions to our customers. It equips them with a powerful provenance narrative for their consumers, the people who enjoy delicious, high-quality and sustainable food and beverage products every day around the world.”
Today, ofi will be joined by Mars, the U.S. Agency for International Development, and the Sustainable Food Lab at an Innovation Forum event ‘Making Choices for Change in the global food system’2 to discuss how the food value chain can work together to make better choices at every stage from plant to palate.
The new Choices for Change strategy and the detailed ambitions supporting it can be accessed on ofi’s website.
References
- ofi's existing product-focused sustainability strategies include Cashew Trail, Cocoa Compass, Coffee LENS, Hazelnut Trail, Almond Trail and Dairy Tracks
- Register for the webinar free here.
About ofi
ofi (olam food ingredients) is a new operating group born out of Olam Group. ofi offers sustainable, natural, value-added food products and ingredients so that consumers can enjoy the healthy and indulgent products they love. It consists of industry-leading businesses of cocoa, coffee, dairy, nuts, and spices. ofi has built a unique global value chain presence including its own farming operations, farm-gate origination, and manufacturing facilities. ofi partners with customers, leveraging its complementary and differentiated portfolio of ‘on-trend’ food products, to co-create solutions that anticipate and meet changing consumer preferences as demand increases for healthier food that’s traceable and sustainable. To subscribe to the ofi newsroom, please visit www.ofi.com/news-and-events (privacy statement here). If you do not wish to receive information from ofi please contact media@ofi.com. Follow @ofi-group on LinkedIn.
About Olam
Olam Group is a leading food and agri-business supplying food, ingredients, feed, and fibre to 20,200 customers worldwide. More information on Olam can be found at www.olamgroup.com.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240618240708/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Swiss-Based Debiopharm Seeks to Boost Innovation in Japanese Cancer Research Through the New "Ideal Japan” Program18.11.2025 08:00:00 CET | Press release
After 20 years of the prestigious JCA (Japanese Cancer Association) Mauvernay Award in Japan, Debiopharm is now transitioning its longstanding support for Japanese research to the new IDEAL Japan initiativeThe “Innovation Debiopharm Academia Life Science” (IDEAL) program is designed to financially and scientifically support academic research with the goal of accelerating the translation of innovation into novel therapies for patientsThe first IDEAL Japan agreement was signed with the National Cancer Center Japan Research Institute Laboratory of Genome Stability Maintenance to advance research in early-stage colon cancer Debiopharm (www.debiopharm.com), a Swiss biopharmaceutical company aiming to cure cancer and infectious diseases, is pleased to announce today the launch of the new IDEAL Japan initiative. This program was initiated to provide financial support to Japanese academic researchers in order to facilitate the transformation of academic innovation into novel therapeutic approa
Avanzanite Bioscience Secures €32M Series A Investment from MVM Partners18.11.2025 07:00:00 CET | Press release
MVM Partners joins as Avanzanite’s first institutional investor. Funding will scale Avanzanite’s existing infrastructure in all 32 countries in Europe, propel current launches, and support further product alliances and acquisitions. In just 3 years, Avanzanite has entered 3 strategic alliances and actively launched 3 rare disease medicines. Avanzanite’s Q3 2025 revenue tripled year-on-year and climbed over 20% quarter-on-quarter. Avanzanite is a unique, fully integrated partner for biotech and pharma innovators seeking to market and distribute their rare disease medicines in Europe. A new pan-European standard is being set for orphan medicine launches and patient access, with no one left behind. Avanzanite Bioscience B.V. (Avanzanite), a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today announced a €32 million Series A growth investment from MVM Partners (MVM), a leading global life-science private equity firm. This press release
Over 30 Million Users Benefit From Ant International’s Bettr Credit Tech Solutions18.11.2025 04:35:00 CET | Press release
Powering the Next Wave of MSME Growth with Digital Platforms in Emerging MarketsThere was a threefold year-on-year increase in eligible customers reached through partners using Bettr's credit tech solutions by the end of October 2025.The solution features an AI-driven, alternative-data-powered credit engine that can help partner platforms to cut credit policy deployment from weeks to minutes.Partnership with Dock, a leading Brazilian payments and banking technology provider, will expand the deployment of Bettr’s credit tech solutions. Bettr, a leading provider of inclusive financial services and technology business under Ant International, today announced the launch of its proprietary tailored, one-stop credit tech solutions designed to help digital platforms build and scale their lending businesses to better serve micro, small and medium enterprises (MSMEs) in emerging markets. Bettr's credit tech solutions supported over 30 million customers to gain access to credit services through
Ant International Deepens Participation in Project Ensemble as New Architecture Community Member18.11.2025 04:00:00 CET | Press release
Ant International has been a participant in the Ensemble Sandbox since 2024 Ant International today announced it has joined Project Ensemble’s Architecture Community to support the design and advancement of Hong Kong’s tokenisation ecosystem. As a Community member, it will be more involved in defining industry standards and supporting the development of Hong Kong’s tokenisation market, together with the Hong Kong Monetary Authority (HKMA) and leading peers. A fintech representative on the Community, Ant International will also contribute its technological and innovation capabilities in tokenisation to support broader industry adoption. This comes at a time when Project Ensemble reaches a new milestone with EnsembleTX, which will see it move from sandbox experiments to live market use within a pilot environment. Through EnsembleTX, Ant International will continue to broaden its partnerships with banks and other committee members, contributing to real-world use cases of tokenisation in r
Celltrion Announces European Commission Approval of Additional Line Extension for Omlyclo™ 300mg18.11.2025 03:51:00 CET | Press release
Omlyclo™ (omalizumab) is the first and only omalizumab biosimilar approved in EuropeOmlyclo™ 300 mg/2ml prefilled syringe (PFS) presentation is now approved in EU offering a simpler dosing schedule and improved patient adherence The European Commission (EC) has granted a line extension in the European Union (EU) for Celltrion’s Omlyclo™ (omalizumab), Europe’s first and only omalizumab biosimilar, for the 300 mg/2ml prefilled syringe (PFS).The European Commission (EC) approved Omlyclo™ 75 mg/0.5ml and 150mg/1ml solution for injection in pre-filled syringe in May 2024. Omlyclo™ is indicated for the treatment of patients with allergic asthma, chronic spontaneous urticaria (CSU) and chronic rhinosinusitis with nasal polyps (CRSwNP). “The additional strength of Omlyclo™ 300mg can significantly decrease the frequency of injections, and reduce injection burden and discomfort, without compromising efficacy and safety,” said Nam Lee, Vice President of Global Medical Affairs at Celltrion. “These
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
